Mesenchymal stem cell-secreted prostaglandin E(2) ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization

BACKGROUND: Acute liver failure (ALF) is an acute inflammatory liver disease with high mortality. Previous preclinical and clinical trials have confirmed that mesenchymal stem cell (MSC) is a promising therapeutic approach; however, the effect is not satisfied as the underlying molecular mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinglin, Liu, Yang, Ding, Haoran, Shi, Xiaolei, Ren, Haozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792134/
https://www.ncbi.nlm.nih.gov/pubmed/33413632
http://dx.doi.org/10.1186/s13287-020-02070-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792134/
https://www.ncbi.nlm.nih.gov/pubmed/33413632
http://dx.doi.org/10.1186/s13287-020-02070-2

Ejemplares similares